Donate Now

Research Updates.
Real Stories.
Things Worth Knowing.

Updated International Recommendations Encourage People with Arthritis to Move More

Vancouver (May 11, 2026) — A study from Arthritis Research Canada scientists Dr. J. Antonio Aviña-Zubieta and Na Lu, along with Sadaf Sediqi and Dr. Julia Simard from Stanford University, found that taking hydroxychloroquine during early pregnancy does not significantly reduce the risk of high blood pressure complications like preeclampsia and pre-term births among women living with lupus. […]

...
Read More

Updated International Recommendations Encourage People with Arthritis to Move More

Vancouver (May 7, 2026) — An international task force with 26 team members, including Arthritis Research Canada affiliate scientist Dr. Denislav Orlinov, reinforces the importance of physical activity for people with arthritis. The existing European Alliance of Associations for Rheumatology (EULAR) recommendations from 2018 for physical activity in people with inflammatory arthritis and osteoarthritis required an update. […]

...
Read More

Arthritis Research Canada Takes Steps to Improve Equity, Diversity, and Inclusion in Research

Arthritis Research Canada Takes Steps to Improve Equity, Diversity, and Inclusion in Research January 3, 2025 (Vancouver) – A New Arthritis Research Canada study reveals a need to include more underrepresented populations in research to improve the quality of care for people living with arthritis. “We know that health outcomes vary according to a person’s […]

...
Read More

Study Clarifies the Long-term Eye Safety of Popular Treatment Hydroxychloroquine

Study Clarifies the Long-term Eye Safety of Popular Treatment Hydroxychloroquine Vancouver (March 31, 2026) —A new study led by Arthritis Research Canada trainee Dr. Narsis Daftarian and scientists Dr. J. Antonio Aviña-Zubieta and Dr. Hui Xie provided new insight into the long-term safety of hydroxychloroquine, a commonly prescribed medication for people living with rheumatic diseases. […]

...
Read More

Study Finds Class of Diabetes Medication Also Reduces Gout Flares

Study Finds Class of Diabetes Medication Also Reduces Gout Flares Vancouver (March 27, 2026) — A study led by Arthritis Research Canada scientists Dr. Natalie McCormick, Dr. J. Antonio Aviña-Zubieta, and Dr. Hyon Choi, and trainee Sharan Rai, explored a way to better manage gout and type 2 diabetes with a class of medication called […]

...
Read More

Latest News​

Successful stories from people impacted and living with Arthritis

arc_placeholder_new

Updated International Recommendations Encourage People with Arthritis to Move More

arthritis research physical activity

Vancouver (May 11, 2026) — A study from Arthritis Research Canada scientists Dr. J. Antonio Aviña-Zubieta and Na Lu, along with Sadaf Sediqi...

Read Article
arc_placeholder_new

Updated International Recommendations Encourage People with Arthritis to Move More

arthritis research hydroxychloroquine lupus pregnancy

Vancouver (May 7, 2026) — An international task force with 26 team members, including Arthritis Research Canada affiliate scientist Dr....

Read Article
2025-Megan-Thomas-Release_EDI-Research_Featured-Image

Arthritis Research Canada Takes Steps to Improve Equity, Diversity, and Inclusion in Research

arthritis Arthritis Research Canada Canada diversity equity health disparities inclusion Mary De Vera Megan Thomas

Arthritis Research Canada Takes Steps to Improve Equity, Diversity, and Inclusion in Research January 3, 2025 (Vancouver) – A New...

Read Article
arc_placeholder_new

Study Clarifies the Long-term Eye Safety of Popular Treatment Hydroxychloroquine

arthritis research hydroxychloroquine

Study Clarifies the Long-term Eye Safety of Popular Treatment Hydroxychloroquine Vancouver (March 31, 2026) —A new study led by Arthritis...

Read Article

Don’t miss what’s next.

Research updates, community stories, and things worth knowing. Delivered to your inbox.